<DOC>
	<DOCNO>NCT00975104</DOCNO>
	<brief_summary>Randomized , Double-blind , Placebo-controlled Dose Ranging Study Evaluate Safety Efficacy AMG 745 Age-associated Muscle Loss</brief_summary>
	<brief_title>AMG 745 Subjects With Age-associated Muscle Loss</brief_title>
	<detailed_description />
	<criteria>Limited exercise tolerance Rapid Assessment Physical Activity ( RAPA ) score ≤ 3 Hand grip ( dominant hand ) : men ≤ 30.3 kg , woman ≤ 19.3 kg Walk speed ≤ 0.8 m/s ( base 4 meter walk ) Subject weight &gt; 137 kg ( 300 lb ) , Body Mass Index ( BMI ) &gt; 32 kg/m2 Primary muscle disease myopathy Recent immobilization , major trauma leg within 6 month Knee hip replacement within 12 month low extremity amputation Significant laboratory abnormality Significant comorbidities medical history Weight loss ( intentional unintentional ) &gt; 5 kg 12 week Unable complete MRI scan</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Aging</keyword>
	<keyword>Frailty</keyword>
	<keyword>Sedentary</keyword>
	<keyword>Immobilization</keyword>
	<keyword>Atrophy</keyword>
	<keyword>Muscle Wasting</keyword>
	<keyword>Physical Activity</keyword>
</DOC>